Innovation a factor in insulin drug prices tripling over past decade

The price of insulin, a drug that's been around for nearly a century, has been steadily rising, surpassing the cost of similar treatments and becoming an increasingly unaffordable necessity for the roughly 6 million Americans with diabetes. And in this case, innovation may be to blame.  READ MORE